Logo image of CHNR

CHINA NATURAL RESOURCES INC (CHNR) Stock Fundamental Analysis

NASDAQ:CHNR - VGG2110U1176 - Common Stock

3.7 USD
+0.07 (+2.02%)
Last: 8/22/2025, 8:00:00 PM
Fundamental Rating

1

CHNR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. The financial health of CHNR is average, but there are quite some concerns on its profitability. CHNR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CHNR has reported negative net income.
CHNR had a negative operating cash flow in the past year.
In the past 5 years CHNR reported 4 times negative net income.
In the past 5 years CHNR reported 4 times negative operating cash flow.
CHNR Yearly Net Income VS EBIT VS OCF VS FCFCHNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

With a Return On Assets value of -1.21%, CHNR perfoms like the industry average, outperforming 50.64% of the companies in the same industry.
CHNR has a Return On Equity (-3.59%) which is in line with its industry peers.
Industry RankSector Rank
ROA -1.21%
ROE -3.59%
ROIC N/A
ROA(3y)-4.54%
ROA(5y)-4.7%
ROE(3y)-18.55%
ROE(5y)-21.22%
ROIC(3y)N/A
ROIC(5y)N/A
CHNR Yearly ROA, ROE, ROICCHNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

CHNR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CHNR Yearly Profit, Operating, Gross MarginsCHNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for CHNR has been increased compared to 1 year ago.
Compared to 5 years ago, CHNR has more shares outstanding
There is no outstanding debt for CHNR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHNR Yearly Shares OutstandingCHNR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
CHNR Yearly Total Debt VS Total AssetsCHNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -1.94, we must say that CHNR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CHNR (-1.94) is worse than 90.38% of its industry peers.
There is no outstanding debt for CHNR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.94
ROIC/WACCN/A
WACCN/A
CHNR Yearly LT Debt VS Equity VS FCFCHNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.25 indicates that CHNR may have some problems paying its short term obligations.
CHNR has a worse Current ratio (0.25) than 94.87% of its industry peers.
CHNR has a Quick Ratio of 0.25. This is a bad value and indicates that CHNR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.25, CHNR is not doing good in the industry: 94.23% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25
CHNR Yearly Current Assets VS Current LiabilitesCHNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.81% over the past year.
CHNR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)88.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.75%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHNR Yearly Revenue VS EstimatesCHNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2019 2020 2021 2022 50M 100M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CHNR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CHNR Price Earnings VS Forward Price EarningsCHNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CHNR Per share dataCHNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CHNR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHINA NATURAL RESOURCES INC

NASDAQ:CHNR (8/22/2025, 8:00:00 PM)

3.7

+0.07 (+2.02%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-15 2025-05-15
Earnings (Next)12-29 2025-12-29
Inst Owners0.45%
Inst Owner Change-82.22%
Ins Owners3.15%
Ins Owner ChangeN/A
Market Cap4.55M
Analysts0
Price TargetN/A
Short Float %8.77%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.37
P/tB 0.37
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.84
OCFYN/A
SpS0
BVpS9.97
TBVpS9.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.21%
ROE -3.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.54%
ROA(5y)-4.7%
ROE(3y)-18.55%
ROE(5y)-21.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.14%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z -1.94
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)0.63%
Cap/Depr(5y)2.88%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-155.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-155.65%
OCF growth 3YN/A
OCF growth 5YN/A